mhurhangee/patent-ind-claim-en huggingface dataset:
Household refrigeration appliance with an inner container and with an outer housing which surrounds the inner container , wherein walls of the inner container delimit a receiving space for food, wherein the inner container is embodied by at least two separate partial pieces , wherein each of the at least two partial pieces comprises at least one wall delimiting the receiving space , wherein an insulating material in the form of an insulating foam is provided between the inner container and the outer housing, characterised in that the insulating material ensures that the at least two separate partial pieces are fixed in relation to one another.
A catheter having an expansile distal tip, the catheter tip having a constricted delivery configuration and an expanded deployed configuration, and comprising a support frame and an elastic sleeve extending over the frame, the sleeve being expandable in the deployed configuration to define an enlarged distal tip; wherein the support frame is cut from a tube and the cut pattern defines ring members and axially extending connections between the ring members and characterised in that the support frame comprises: a highly flexible region just proximal of the expansile distal tip; and a section proximal of the highly flexible region that is configured to expand to accept a clot a highly flexible region just proximal of the expansile distal tip; and a section proximal of the highly flexible region that is configured to expand to accept a clot
A prosthetic heart valve device for expanded implantation within a heart chamber that is in fluid communication with an annulus comprising an annular plane and with a native valve having leaflets, the device comprising: a base section comprising a lower surface that is at least partially disposed on the annular plane; an atrial dome section in pressured and frictional engagement with the chamber roof when the device is expanded and implanted; an intermediate section comprising a flexible and expandable mesh and operatively attached to the base section and the atrial dome section ; and a central cylinder valve support comprising a lower surface, the central cylinder valve support operatively attached to base section and comprising at least one prosthetic valve leaflet operatively attached therein, wherein the lower surface is located on or above the annular plane, wherein the expanded and implanted device comprising no structural engagement presence in, or engagement with, with the native valve leaflets. a base section comprising a lower surface that is at least partially disposed on the annular plane; an atrial dome section in pressured and frictional engagement with the chamber roof when the device is expanded and implanted; an intermediate section comprising a flexible and expandable mesh and operatively attached to the base section and the atrial dome section ; and a central cylinder valve support comprising a lower surface, the central cylinder valve support operatively attached to base section and comprising at least one prosthetic valve leaflet operatively attached therein, wherein the lower surface is located on or above the annular plane, wherein the expanded and implanted device comprising no structural engagement presence in, or engagement with, with the native valve leaflets.
A lens, which is a spectacle lens comprising multilayer films on an object-side surface and an eyeball-side surface of a lens substrate, wherein - the reduction ratio by reflection of light in a wavelength band of 800-1400 nm in the lens is ≥ 45.0%, - the ratio of a mean reflectance on the eyeball-side surface of the lens to that on the object-side surface of the lens is 0.2-0.8 in the wavelength band, and - the mean reflectance on the eyeball-side surface in a wavelength band of 315-400 nm is ≤ 5.0%. - the reduction ratio by reflection of light in a wavelength band of 800-1400 nm in the lens is ≥ 45.0%, - the ratio of a mean reflectance on the eyeball-side surface of the lens to that on the object-side surface of the lens is 0.2-0.8 in the wavelength band, and - the mean reflectance on the eyeball-side surface in a wavelength band of 315-400 nm is ≤ 5.0%.
A system for treating osteoarthritis in a hip joint, the hip joint comprising an acetabulum , being part of the pelvic bone , and a caput femur , being a part of the femoral bone, said system comprising: - at least one sealing member adapted to be placed inside of the hip joint, and - an injecting member (92; 105) adapted to be used in connection with said at least one sealing member, said injecting member being adapted to inject material into a hollow space, wherein said system further comprises - a material adapted to be injected with said injecting member into said hollow space, wherein said material is adapted to transform from a fluid state to a solid state after being injected, characterised in that said at least one sealing member is configured to define said hollow space together with the caput femur, or an artificial replacement therefor, and the acetabulum, or an artificial replacement therefor, of said human patient, whereby said hollow space is sealed, and said material is configured for resurfacing or replacing bearing contacting surfaces of the hip joint. - at least one sealing member adapted to be placed inside of the hip joint, and - an injecting member (92; 105) adapted to be used in connection with said at least one sealing member, said injecting member being adapted to inject material into a hollow space, wherein said system further comprises - a material adapted to be injected with said injecting member into said hollow space, wherein said material is adapted to transform from a fluid state to a solid state after being injected, characterised in that said at least one sealing member is configured to define said hollow space together with the caput femur, or an artificial replacement therefor, and the acetabulum, or an artificial replacement therefor, of said human patient, whereby said hollow space is sealed, and said material is configured for resurfacing or replacing bearing contacting surfaces of the hip joint.
A method for producing a holding seal material including alumina fibers, the method comprising: a spinning mixture preparing step of mixing an aqueous solution of basic aluminum chloride and silica sol to achieve a proportion of basic aluminum chloride of 82.8 to 97.7 wt% and a proportion of silica of 17.2 to 2.3 wt% to prepare a spinning mixture; an alumina fiber precursor producing step of spinning the spinning mixture into alumina fiber precursors by a blowing method at 80°C to 140°C; an aggregate producing step of collecting the alumina fiber precursors to produce an alumina fiber precursor aggregate having a moisture content of 5 to 10%; a conveying step of moisturizing the alumina fiber precursor aggregate to a moisture content of 10 to 18% and conveying the alumina fiber precursor aggregate; a sheet producing step of compressing the alumina fiber precursor aggregate into a sheet having a moisture content of 10 to 18%; a needle punching step of needle punching the sheet under the condition of 2 to 50 marks/cm 2 ; and a firing step of firing the sheet having a moisture content of 10 to 18% at 1200°C to 1300°C. a spinning mixture preparing step of mixing an aqueous solution of basic aluminum chloride and silica sol to achieve a proportion of basic aluminum chloride of 82.8 to 97.7 wt% and a proportion of silica of 17.2 to 2.3 wt% to prepare a spinning mixture; an alumina fiber precursor producing step of spinning the spinning mixture into alumina fiber precursors by a blowing method at 80°C to 140°C; an aggregate producing step of collecting the alumina fiber precursors to produce an alumina fiber precursor aggregate having a moisture content of 5 to 10%; a conveying step of moisturizing the alumina fiber precursor aggregate to a moisture content of 10 to 18% and conveying the alumina fiber precursor aggregate; a sheet producing step of compressing the alumina fiber precursor aggregate into a sheet having a moisture content of 10 to 18%; a needle punching step of needle punching the sheet under the condition of 2 to 50 marks/cm 2 ; and a firing step of firing the sheet having a moisture content of 10 to 18% at 1200°C to 1300°C.
A bearing assembly comprising: a case ; a bearing spring positioned inside the case ; a first seal positioned between the case and the bearing spring ; and a second seal (64; 164; 264; 364) positioned between the case and the bearing spring and spaced apart from the first seal , wherein the second seal (64; 164; 264; 364) is an adjustable seal that is movable between a closed position and an opened position to inhibit or allow, respectively, a fluid to flow from a cavity that is defined by the case , the bearing spring , the first seal and the second seal (64; 164; 264; 364), characterised in that the second seal (64; 164; 264; 364) is a valve, the valve (64; 164; 264; 364) comprises a first annular ring (70; 170; 270; 370) and a second annular ring (72; 172; 272; 372), and the second annular ring (72; 172; 272; 372) is moveable relative to the first annular ring (70; 170; 270; 370). a case ; a bearing spring positioned inside the case ; a first seal positioned between the case and the bearing spring ; and a second seal (64; 164; 264; 364) positioned between the case and the bearing spring and spaced apart from the first seal , wherein the second seal (64; 164; 264; 364) is an adjustable seal that is movable between a closed position and an opened position to inhibit or allow, respectively, a fluid to flow from a cavity that is defined by the case , the bearing spring , the first seal and the second seal (64; 164; 264; 364), characterised in that the second seal (64; 164; 264; 364) is a valve, the valve (64; 164; 264; 364) comprises a first annular ring (70; 170; 270; 370) and a second annular ring (72; 172; 272; 372), and the second annular ring (72; 172; 272; 372) is moveable relative to the first annular ring (70; 170; 270; 370).
A plurality of medical cap devices removably adhered to a substrate , each medical cap device comprises at least: a bottom end having a cavity ; and a closed top end opposite the bottom end; wherein each medical cap device is removably adhered to the substrate by the top end, wherein the bottom end is covered by a removable protective film to thereby seal the cavity, and wherein the substrate is flexible and rollable. a bottom end having a cavity ; and a closed top end opposite the bottom end; wherein each medical cap device is removably adhered to the substrate by the top end, wherein the bottom end is covered by a removable protective film to thereby seal the cavity, and wherein the substrate is flexible and rollable.
A skin compatible component attachable to mammalian skin comprising: a silicone polymer network derived from the addition curing of a first part including a vinyl functionalised siloxane polymer and a second part including a silicon hydride containing crosslinker, in the presence of a metal catalyst; and a superabsorbent particulate distributed within the polymer network configured to absorb moisture from the skin; wherein the silicone polymer network comprises a foamed structure. a silicone polymer network derived from the addition curing of a first part including a vinyl functionalised siloxane polymer and a second part including a silicon hydride containing crosslinker, in the presence of a metal catalyst; and a superabsorbent particulate distributed within the polymer network configured to absorb moisture from the skin; wherein the silicone polymer network comprises a foamed structure.
A method for detecting the presence of a pathogen in a whole blood sample, the method comprising: (a) mixing from 0.05 to 4.0 mL of a provided whole blood sample suspected of containing a pathogen with an erythrocyte lysis agent, thereby producing disrupted red blood cells; (b) centrifuging the mixture of step (a) to form a supernatant and a pellet; (c) discarding some or all of the supernatant of step (b) and resuspending the pellet to form an extract; (d) lysing cells of the extract of step (c) directly to form a lysate; and (e) placing the lysate of step (d) in a container and amplifying a target nucleic acid in the lysate to form an amplified lysate solution including the target nucleic acid, wherein the target nucleic acid is characteristic of the pathogen to be detected; (f) placing the amplified liquid sample in a detecting device; (g) on the basis of the result of step (f), detecting the pathogen, wherein the pathogen is selected from bacteria and fungi, wherein the method is capable of detecting a pathogen concentration of 10 cells/mL in the whole blood sample. (a) mixing from 0.05 to 4.0 mL of a provided whole blood sample suspected of containing a pathogen with an erythrocyte lysis agent, thereby producing disrupted red blood cells; (b) centrifuging the mixture of step (a) to form a supernatant and a pellet; (c) discarding some or all of the supernatant of step (b) and resuspending the pellet to form an extract; (d) lysing cells of the extract of step (c) directly to form a lysate; and (e) placing the lysate of step (d) in a container and amplifying a target nucleic acid in the lysate to form an amplified lysate solution including the target nucleic acid, wherein the target nucleic acid is characteristic of the pathogen to be detected; (f) placing the amplified liquid sample in a detecting device; (g) on the basis of the result of step (f), detecting the pathogen, wherein the pathogen is selected from bacteria and fungi,
Rack system with struts and with plug-in connectors for connecting the struts, wherein at least one plug-in connector is arranged on a first strut , the latter forming a carrier strut, and is oriented perpendicularly in relation to the longitudinal axis of the strut, wherein at least one second strut (3a to 3c, 4a to 4d) is designed in the form of a hollow strut and the plug-in connector projects into the end side of the second strut (3a to 3c, 4a to 4d), characterized in that , in the edge region of its end side, the second strut (3a to 3c, 4a to 4d) is connected in one piece to a third strut (3a to 3c, 4a to 4d), wherein the second and the third struts (3a to 3c, 4a to 4d) are positioned at right angles in relation to one another, wherein the second and third struts (3a to 3c, 4a to 4d) are manufactured by a continuous hollow strut (3a to 3c, 4a to 4d) being partially cut open and bent, wherein the open end sides of the struts (3a to 3c, 4a to 4d) are adjacent to one another and are positioned at an angle of 90° in relation to one another.
A method for producing propylene oxide, characterized in that it comprises reacting propylene with hydrogen peroxide in the presence of an organic solvent and a crystalline titanosilicate catalyst that has an MWW structure containing Ti having been incorporated during crystallization, wherein the organic solvent is an organic solvent selected from the group consisting of ketone compounds, nitrile compounds, hydrocarbons and halogenated hydrocarbons, and wherein the oxidation reaction is carried out under a pressure of 0.1 MPa to 20 MPa.
A method for determining a length parameter of an electrode during operation of an electric arc furnace containing a bath, the method comprising: providing the electrode , wherein the electrode has an upper end situated outside the furnace, a lower end situated inside the furnace, a length defined from the upper end to the lower end, and an internal duct extending along the length of the electrode, wherein the internal duct is open at the lower end of the electrode; providing a waveguide having a first end , a second end and a solid core , wherein the waveguide is at least partly received in the internal duct of the electrode with its second end located at or proximate to the lower end of the electrode, wherein the solid core of the waveguide comprises a material having a low dielectric constant and high temperature resistance, and wherein the waveguide includes a plurality of discontinuities located along a length of the waveguide; emitting an electromagnetic radiation signal, from a source through the solid core from the first end toward the second end of the waveguide; receiving, at the first end of the waveguide, a plurality of return signals including: a return signal from the lower end of the electrode; and return signals from the plurality of discontinuities; measuring a time or frequency difference between the emitted signal and the one or more of the plurality of return signals; and calculating the length parameter based on the time or frequency difference. providing the electrode , wherein the electrode has an upper end situated outside the furnace, a lower end situated inside the furnace, a length defined from the upper end to the lower end, and an internal duct extending along the length of the electrode, wherein the internal duct is open at the lower end of the electrode; providing a waveguide having a first end , a second end and a solid core , wherein the waveguide is at least partly received in the internal duct of the electrode with its second end located at or proximate to the lower end of the electrode, wherein the solid core of the waveguide comprises a material having a low dielectric constant and high temperature resistance, and wherein the waveguide includes a plurality of discontinuities located along a length of the waveguide; emitting an electromagnetic radiation signal, from a source through the solid core from the first end toward the second end of the waveguide; receiving, at the first end of the waveguide, a plurality of return signals including: a return signal from the lower end of the electrode; and return signals from the plurality of discontinuities; a return signal from the lower end of the electrode; and return signals from the plurality of discontinuities; measuring a time or frequency difference between the emitted signal and the one or more of the plurality of return signals; and calculating the length parameter based on the time or frequency difference.
A compound of formula (I) wherein X is O or S; R 1 is hydrogen, halogen, methyl or cyano; R 2 is hydrogen, methyl or halogen; R 3 and R 4 are each independently selected from hydrogen, halogen and methyl; R 5 is C 1 -C 5 alkyl, C 2 -C 5 alkenyl, C 3 -C 5 cycloalkyl(C 1 -C 2 )alkyl or C 3 -C 6 cycloalkyl, wherein the alkyl, alkenyl and cycloalkyl groups may be optionally substituted with 1 to 3 substituents independently selected from halogen, cyano, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy and C 1 -C 3 alkylthio; R 6 is hydrogen, cyano or C 1 -C 4 alkyl, wherein the alkyl may be optionally substituted with 1 to 3 substituents independently selected from halogen and C 1 -C 3 alkoxy; A is a direct bond or CR 8 R 9 ; R 7 is CF 3 , C 2 -C 5 alkyl, C 3 -C 7 cycloalkyl, C 2 -C 5 alkenyl, C 4 -C 7 cycloalkenyl, wherein the alkyl, cycloalkyl, alkenyl and cycloalkenyl may be optionally substituted with one or more substituents independently selected from halogen, cyano, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio, C 1 -C 3 haloalkoxy, C 1 -C 3 haloalkylthio, C 3 -C 7 cycloalkyl and phenyl which itself may be optionally substituted with 1 to 3 substituents independently selected from halogen, cyano, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio, C 1 -C 3 haloalkoxy, C 1 -C 3 haloalkylthio and C 3 -C 5 cycloalkyl; and R 8 and R 9 are each independently selected from hydrogen, fluoro and methyl; or a salt, enantiomer or N-oxide thereof. X is O or S; R 1 is hydrogen, halogen, methyl or cyano; R 2 is hydrogen, methyl or halogen; R 3 and R 4 are each independently selected from hydrogen, halogen and methyl; R 5 is C 1 -C 5 alkyl, C 2 -C 5 alkenyl, C 3 -C 5 cycloalkyl(C 1 -C 2 )alkyl or C 3 -C 6 cycloalkyl, wherein the alkyl, alkenyl and cycloalkyl groups may be optionally substituted with 1 to 3 substituents independently selected from halogen, cyano, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy and C 1 -C 3 alkylthio; R 6 is hydrogen, cyano or C 1 -C 4 alkyl, wherein the alkyl may be optionally substituted with 1 to 3 substituents independently selected from halogen and C 1 -C 3 alkoxy; A is a direct bond or CR 8 R 9 ; R 7 is CF 3 , C 2 -C 5 alkyl, C 3 -C 7 cycloalkyl, C 2 -C 5 alkenyl, C 4 -C 7 cycloalkenyl, wherein the alkyl, cycloalkyl, alkenyl and cycloalkenyl may be optionally substituted with one or more substituents independently selected from halogen, cyano, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio, C 1 -C 3 haloalkoxy, C 1 -C 3 haloalkylthio, C 3 -C 7 cycloalkyl and phenyl which itself may be optionally substituted with 1 to 3 substituents independently selected from halogen, cyano, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio, C 1 -C 3 haloalkoxy, C 1 -C 3 haloalkylthio and C 3 -C 5 cycloalkyl; and R 8 and R 9 are each independently selected from hydrogen, fluoro and methyl; or a salt, enantiomer or N-oxide thereof.
An airfoil comprising: an airfoil section having an airfoil wall defining a leading end , a trailing end , and first and second sides joining the leading end and the trailing end, the first and second sides spanning in a longitudinal direction (A1) between first and second ends ; and a multi-piece baffle disposed in an internal core cavity and having a shape complementary to the first and second convex sides, characterized in that : the first and second sides are convex, the first and second convex sides define lateral bounds of an internal core cavity , and the first and second convex sides converge toward each other at each of the first and second ends such that the internal core cavity constricts at the first and second ends. an airfoil section having an airfoil wall defining a leading end , a trailing end , and first and second sides joining the leading end and the trailing end, the first and second sides spanning in a longitudinal direction (A1) between first and second ends ; and a multi-piece baffle disposed in an internal core cavity and having a shape complementary to the first and second convex sides, characterized in that : the first and second sides are convex, the first and second convex sides define lateral bounds of an internal core cavity , and the first and second convex sides converge toward each other at each of the first and second ends such that the internal core cavity constricts at the first and second ends.
An interference alignment module for use in a communication device for communicating with another communication device over a link that is utilized at the substantially same time and with the substantially same frequency resource by a pair of further communication devices , said communication device comprising one or more antenna arrays with which beamforming can be performed and a control circuitry configured to apply beamformers to control beamforming by the one or more antenna arrays , the interference alignment module comprising an interference alignment circuitry configured to determine whether at least one of the beamformers satisfies an interference condition such that a level of interference leaked to the further communication devices by said communication device is below a defined threshold, and, if available, selecting the at least one beamformer for communicating with the other communication device , characterized in that the interference condition is based on channel characteristics between said communication device and at least one of the further communication devices and non-reciprocity mismatch, the non-reciprocity mismatch being a measure indicative of a mismatch of a transmission pattern and a reception pattern of at least one further communication device of said pair of further communication devices .